Key facts
- It has raised $3.1M; the latest was Early Stage VC ($3.1M) in Jan 2026.
- Notable investors include Zhejiang Pure Equity Investment Fund Management.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Xinying Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Xinying Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xinying Medical
Developer of interventional medical equipment intended for cardiovascular procedures. The company offers imaging-guided navigation, precision catheter technologies, minimally invasive surgical instruments, and integrated clinical data support, enabling hospitals and specialized cardiac centers to conduct complex interventions with improved accuracy, reduced procedural risks, enhanced patient safety, and streamlined workflows that facilitate regulatory compliance and accelerate adoption in clinical practice.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2025
- Website
- incardiacho.com/
- Ownership
- Privately Held (backing)
Xinying Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xinying Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xinying Medical in its N-PORT filings yet. We sweep new filings monthly.